PMV PHARMACEUTICALS, INC. Income Tax Expense
PMV PHARMACEUTICALS, INC. (PMVP) reported Income Tax Expense of $3.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-14
- PMV PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was $3.00K, a 40.00% decline year-over-year.
- PMV PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $26.00K.
- PMV PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was -$6.00K, a 108.11% decline year-over-year.
- PMV PHARMACEUTICALS, INC. income tax expense (benefit) for the quarter ending 2025-06-30 was $5.00K.
- PMV PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2025 was -$2.17M.
- PMV PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2024 was -$16.10M, a 805100.00% decline from fiscal 2023.
- PMV PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2023 was $2.00K.
- PMV PHARMACEUTICALS, INC. income tax expense (benefit) for fiscal 2022 was -$9.00K, a 139.13% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00K 10-Q · filed 2026-08-14 | $3.00K 10-Q · filed 2026-08-14 | ||
| 2025-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $20.00K derived: sum of 2 quarters · filed 2026-03-06 | $25.00K derived: sum of 3 quarters · filed 2026-08-14 | -$2.17M 10-K · filed 2026-03-06 |
| 2025-09-30 | -$6.00K 10-Q · filed 2025-11-12 | -$1.00K derived: sum of 2 quarters · filed 2026-08-14 | -$2.20M 10-Q · filed 2025-11-12 | -$2.20M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $5.00K 10-Q · filed 2026-08-14 | -$2.19M 10-Q · filed 2026-08-14 | -$2.19M derived: sum of 3 quarters · filed 2026-08-14 | -$2.12M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$2.20M 10-Q · filed 2026-05-12 | -$2.20M derived: sum of 2 quarters · filed 2026-05-12 | -$2.12M derived: sum of 3 quarters · filed 2026-05-12 | -$18.30M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $74.00K derived: sum of 2 quarters · filed 2026-03-06 | -$16.10M derived: sum of 3 quarters · filed 2026-03-06 | -$16.10M 10-K · filed 2026-03-06 |
| 2024-09-30 | $74.00K 10-Q · filed 2025-11-12 | -$16.10M derived: sum of 2 quarters · filed 2025-11-12 | -$16.10M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$16.17M 10-Q · filed 2025-08-07 | -$16.17M 10-Q · filed 2025-08-07 | ||
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$2.00K derived: sum of 2 quarters · filed 2026-03-06 | $2.00K derived: sum of 3 quarters · filed 2026-03-06 | $2.00K 10-K · filed 2026-03-06 |
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.00K derived: sum of 2 quarters · filed 2024-11-07 | $3.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $4.00K 10-Q · filed 2024-08-08 | $4.00K 10-Q · filed 2024-08-08 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$9.00K derived: sum of 2 quarters · filed 2025-03-03 | -$11.00K derived: sum of 3 quarters · filed 2025-03-03 | -$9.00K 10-K · filed 2025-03-03 |
| 2022-09-30 | -$9.00K 10-Q · filed 2023-11-09 | -$11.00K derived: sum of 2 quarters · filed 2023-11-09 | -$9.00K 10-Q · filed 2023-11-09 | -$9.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$2.00K 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-02-29 | $19.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-10 | $2.00K derived: sum of 2 quarters · filed 2024-02-29 | $21.00K derived: sum of 3 quarters · filed 2024-02-29 | $21.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $19.00K derived: sum of 2 quarters · filed 2024-02-29 | $19.00K derived: sum of 3 quarters · filed 2024-02-29 | $23.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $19.00K 10-Q · filed 2022-11-08 | $19.00K derived: sum of 2 quarters · filed 2022-11-08 | $23.00K 10-Q · filed 2022-11-08 | $24.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $4.00K 10-Q · filed 2022-08-09 | $5.00K derived: sum of 3 quarters · filed 2023-03-01 | $8.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $4.00K 10-Q · filed 2022-05-10 | $5.00K derived: sum of 2 quarters · filed 2023-03-01 | $8.00K derived: sum of 3 quarters · filed 2023-03-01 | $8.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.00K derived: sum of 2 quarters · filed 2023-03-01 | $4.00K derived: sum of 3 quarters · filed 2023-03-01 | $6.00K 10-K · filed 2023-03-01 |
| 2020-09-30 | $3.00K 10-Q · filed 2021-11-12 | $3.00K derived: sum of 2 quarters · filed 2021-11-12 | $5.00K 10-Q · filed 2021-11-12 | $5.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $2.00K 10-Q · filed 2021-08-13 | $2.00K derived: sum of 3 quarters · filed 2022-03-01 | $9.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $2.00K 10-Q · filed 2021-05-14 | $2.00K derived: sum of 2 quarters · filed 2022-03-01 | $9.00K derived: sum of 3 quarters · filed 2022-03-01 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $7.00K derived: sum of 2 quarters · filed 2022-03-01 | $8.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $7.00K 10-Q · filed 2020-11-13 | $8.00K 10-Q · filed 2020-11-13 | ||
| 2018-12-31 | $3.00K 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |